Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot hand coach lets patients rehab at home without a therapist

NCT ID NCT07182734

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a hand rehabilitation device called ReHandyBot, paired with a smartphone app called RehabCoach, can help people recover after a stroke, traumatic brain injury, or orthopedic problem. Thirty participants will first use the device under supervision at a clinic, then take it home for daily unsupervised therapy. The goal is to see if patients can use the tools safely and stick to their therapy schedule on their own.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ReHandyBot hand rehabilitation device and RehabCoach smartphone app
What this could lead to
If successful, this could show that home-based robotic therapy is safe and effective, potentially expanding rehab options for stroke, brain injury, and orthopedic patients.
What could go wrong
This is a small, early feasibility study with only 30 participants. It does not measure long-term recovery, and the device may not work well for everyone or may have technical issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Eligibility criteria for neurological patients Inclusion criteria: * Informed Consent signed by the subject. * Female and male patients between 18 and 90 years old. * Stroke or traumatic brain injury (recruitment within 6 months from event onset). * Presence of a motor and/or sensory impairment of the upper limb as assessed by the responsible therapist. * Possibility (e.g., enough space) to set up the ReHandyBot at home. Exclusion criteria: * Modified Ashworth Scale \> 2 for one or more of the following muscles: shoulder adductors, forearm pronator and supinator, flexors and extensors of elbow, wrist and fingers. * Moderate to severe aphasia: Goodglass-Kaplan's scale \< 3. * Moderate to severe cognitive deficits: levels of cognitive functioning-revised (LCF-R) \< 9. * Functional impairment of the upper limb due to other pathologies. * Severe pain in the affected arm: visual analogue scale for pain (VASp) ≥ 5. * Other pathologies which may interfere with the study. * After discharge, the patient will go to an assisted living facility (e.g., care home). Eligibility criteria for orthopedic patients Inclusion criteria: * Informed Consent signed by the subject. * Female and male patients between 18 and 90 years old. * Clinic stay due to an orthopedic-related condition (e.g., surgery, trauma, burns). * Presence of a motor and/or sensory impairment of the upper limb as assessed by the responsible therapist. * Possibility (e.g., enough space) to set up the ReHandyBot at home. Exclusion criteria: * Moderate to severe aphasia: Goodglass-Kaplan's scale \< 3. * Moderate to severe cognitive deficits: levels of cognitive functioning-revised (LCF-R) \< 9. * Functional impairment of the upper limb due to other pathologies. * Severe pain in the affected arm: visual analogue scale for pain (VASp) ≥ 5. * Other pathologies which may interfere with the study. * After discharge, the patient will go to an assisted living facility (e.g., care home).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rehabilitation after neurological or orthopaedic injuries are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.